The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...

People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large study that comes ...

The ACLU’s Chase Strangio will become the first openly transgender lawyer to argue at the US Supreme Court, making his high ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Researchers conducted a cross-sectional analysis to evaluate bone health among menopausal women in Zimbabwe with and without human immunodeficiency virus.

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Dispatch and carefully placed it inside my copy of And The Band Played On: Politics, People, and the AIDS Epidemic – his most ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

Leerink upgraded Gilead (GILD) to Outperform from Market Perform with a price target of $96, up from $74. The stock has appreciated following ...

Gilead and Merck said their once-weekly pill to treat HIV resulted in a comparable level of viral suppression compared to a ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...